Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BROOKFIELD BANCSHARES, INC. AND FIRST NATIONAL BANK OF BROOKFIELD ANNOUNCE EXECUTION OF MERGER AGREEMENT TO ACQUIRE NSTS BANCORP, INC. AND NORTH SHORE TRUST AND SAVINGS
-
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
-
DoubleDown Interactive First Quarter 2026 Revenue Rises 12.7% and Earnings per Fully Diluted Common Share Increases 48.4%
-
Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108
-
Herzfeld Credit Income Fund, Inc. Provides April 2026 Net Asset Value Update
-
Public Policy Holding Company, Inc. Announces Q1 2026 Financial Results
-
Sezzle Provides Update on Antitrust Case Against Shopify
-
Ring Energy Announces Proposed Public Offering of Common Stock
-
Sun Country Unveils Retro Livery Honoring 43-Year Legacy
-
Spectral AI Announces 2026 First Quarter Financial Results
-
Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates
-
Lumexa Imaging Announces First Quarter 2026 Results
-
Interpace Biosciences Announces First Quarter 2026 Financial and Business Results
-
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
-
Black Rock Coffee Bar, Inc. Reports First Quarter 2026 Results
-
Reed’s Reports First Quarter 2026 Results
-
BioStem Technologies to Present at the 16th Annual LD Micro Invitational
-
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
-
Phillips Edison & Company Declares Monthly Dividend Distributions; Announces Results of Annual Meeting of Stockholders
-
Beyond Oil Enters Revenue Execution Phase, Advancing Strategic Customer Adoption and Expanding Direct Sales
-
CNB Financial Corporation Announces Quarterly Dividend For Common Stock
-
Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference
-
Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress
-
LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
BranchOut Food Inc. Announces First Quarter 2026 Earnings Call and Shareholder Update
-
Lifecore Biomedical to Participate at CDMO Live Europe
-
Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
-
Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress
-
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
-
Espey Mfg. & Electronics Corp. reports third quarter results
-
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
-
Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference
-
Red Cat Announces Proposed Public Offering of Common Stock
-
Biomea Fusion to Participate at Upcoming Investor Conferences
-
Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs
-
PEDEVCO to Participate in the LD Micro Invitational XVI Conference
-
XBP Global Schedules Conference Call for First Quarter 2026 Financial Results
-
Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers
-
GrowGeneration Reports First Quarter 2026 Financial Results
-
High Roller Technologies Provides Business Update for Prediction Markets Launch; Reports First Quarter 2026 Results
-
Mobile Infrastructure Reports First Quarter 2026 Financial Results
-
Phillips Edison & Company Declares Monthly Dividend Distributions; Announces Results of Annual Meeting of Stockholders
-
MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 Guidance
-
TELA Bio Reports First Quarter 2026 Financial Results
-
Astera Labs Announces Second Quarter 2026 Financial Conference Participation
-
Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment
-
Black Rock Coffee Bar Announces Jon Vingo as Chief Development Officer
-
Jushi Holdings Inc. Reports First Quarter 2026 Financial Results

